KWILP
CLDX icon

Kiwi Wealth Investments Limited Partnership’s Celldex Therapeutics CLDX Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-27,477
Closed -$936K – 207
2022
Q1 		$936K Sell
27,477
-24,498
-47% -$783K 0.05% 189
2021
Q4 		$2.01M Buy
51,975
+35,073
+208% +$1.53M 0.1% 173
2021
Q3 		$913K Buy
+16,902
New +$793K 0.05% 210

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's CLDX Position: Q2 2022 in Review

Kiwi Wealth Investments Limited Partnership sold out of Celldex Therapeutics (CLDX) in Q2 2022, closing a stake of 27,477 shares — an estimated $936K sold.

Kiwi Wealth Investments Limited Partnership first reported a position in CLDX in Q3 2021 and held it in 3 quarters. The position peaked at $2.01M in Q4 2021. 157 funds tracked by Wall St. Rank hold CLDX as of Q2 2022.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Celldex Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 27,477 Celldex Therapeutics shares in Q2 2022, an estimated $936K.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Celldex Therapeutics in Q3 2021 and held it in 3 quarters.
  • Kiwi Wealth Investments Limited Partnership's Celldex Therapeutics position peaked at $2.01M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2022.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q2 2022, filed 12 Aug 2022.